1. Home
  2. OCS vs YALA Comparison

OCS vs YALA Comparison

Compare OCS & YALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • YALA
  • Stock Information
  • Founded
  • OCS 2003
  • YALA 2016
  • Country
  • OCS Switzerland
  • YALA United Arab Emirates
  • Employees
  • OCS N/A
  • YALA N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • YALA Computer Software: Programming Data Processing
  • Sector
  • OCS Health Care
  • YALA Technology
  • Exchange
  • OCS Nasdaq
  • YALA Nasdaq
  • Market Cap
  • OCS 956.4M
  • YALA 1.1B
  • IPO Year
  • OCS N/A
  • YALA 2020
  • Fundamental
  • Price
  • OCS $17.85
  • YALA $7.79
  • Analyst Decision
  • OCS Strong Buy
  • YALA
  • Analyst Count
  • OCS 3
  • YALA 0
  • Target Price
  • OCS $35.67
  • YALA N/A
  • AVG Volume (30 Days)
  • OCS 11.4K
  • YALA 861.0K
  • Earning Date
  • OCS 08-21-2025
  • YALA 08-11-2025
  • Dividend Yield
  • OCS N/A
  • YALA N/A
  • EPS Growth
  • OCS N/A
  • YALA 14.19
  • EPS
  • OCS N/A
  • YALA 0.81
  • Revenue
  • OCS $960,668.00
  • YALA $348,190,638.00
  • Revenue This Year
  • OCS $11.49
  • YALA $7.52
  • Revenue Next Year
  • OCS $1,784.02
  • YALA $6.88
  • P/E Ratio
  • OCS N/A
  • YALA $9.59
  • Revenue Growth
  • OCS N/A
  • YALA 6.79
  • 52 Week Low
  • OCS $10.79
  • YALA $3.77
  • 52 Week High
  • OCS $23.08
  • YALA $9.29
  • Technical
  • Relative Strength Index (RSI)
  • OCS 46.62
  • YALA 48.08
  • Support Level
  • OCS $17.51
  • YALA $7.50
  • Resistance Level
  • OCS $18.16
  • YALA $7.80
  • Average True Range (ATR)
  • OCS 0.36
  • YALA 0.39
  • MACD
  • OCS 0.01
  • YALA -0.12
  • Stochastic Oscillator
  • OCS 40.48
  • YALA 16.20

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About YALA Yalla Group Limited each representing one

Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The Group has one operating segment, which is the social networking and entertainment platform.

Share on Social Networks: